Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oxytrol Switch Should Hinge On Symptom ID, Not Diagnosis – Merck Consultant

This article was originally published in The Tan Sheet

Executive Summary

Merck’s proposed Rx-to-OTC switch of Oxytrol for Women is about identifying symptoms of overactive bladder, not diagnosing the condition, says Eric Brass, former chair of FDA’s Nonprescription Drugs Advisory Committee. Several NDAC members Nov. 9 insisted OAB should be diagnosed before treatment.

Advertisement

Related Content

Merck’s Oxytrol Could Be OTC Trailblazer For Chronic Conditions
Merck’s Oxytrol Could Be OTC Trailblazer For Chronic Conditions
Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch
Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch
Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch
Promise Of A New Day For Rx-To-OTC Switch Ruled 2012 In “The Tan Sheet”
Perrigo Eyes $115 Billion In Rx-To-OTC Switches On The Horizon
NDAC Puts Hitch In Oxytrol Switch With Negative Self-Selection Vote
FDA Advisors Say Greater Insight Needed On Self-Selection Of OTC Statins
Prilosec 1 Self-Selected Correctly By 81% Of Actual Use Study Participants

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106086

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel